226 related articles for article (PubMed ID: 19956772)
1. Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.
Han L; Wierenga AT; Rozenveld-Geugien M; van de Lande K; Vellenga E; Schuringa JJ
PLoS One; 2009 Nov; 4(11):e7989. PubMed ID: 19956772
[TBL] [Abstract][Full Text] [Related]
2. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.
Schepers H; van Gosliga D; Wierenga AT; Eggen BJ; Schuringa JJ; Vellenga E
Blood; 2007 Oct; 110(8):2880-8. PubMed ID: 17630355
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.
Sun H; Tsai Y; Nowak I; Liesveld J; Chen Y
Stem Cell Res; 2012 Sep; 9(2):77-86. PubMed ID: 22683680
[TBL] [Abstract][Full Text] [Related]
4. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
[TBL] [Abstract][Full Text] [Related]
5. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
6. HGF activates signal transduction from EPO receptor on human cord blood CD34+/CD45+ cells.
Iguchi T; Sogo S; Hisha H; Taketani S; Adachi Y; Miyazaki R; Ogata H; Masuda S; Sasaki R; Ito M; Fukuhara S; Ikehara S
Stem Cells; 1999; 17(2):82-91. PubMed ID: 10195568
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of umbilical cord blood hematopoietic progenitor cells by combinations of cytokines.
Urashima M; Hoshi Y; Akiyama M; Kamijo M; Kato Y; Akatsuka J; Maekawa K; Matsuzaki M; Ohnishi J; Kaihara C
Acta Paediatr Jpn; 1995 Apr; 37(2):160-5. PubMed ID: 7540792
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
9. Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions.
Denning-Kendall P; Singha S; Bradley B; Hows J
Stem Cells; 2003; 21(1):61-70. PubMed ID: 12529552
[TBL] [Abstract][Full Text] [Related]
10. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
Olthof SG; Fatrai S; Drayer AL; Tyl MR; Vellenga E; Schuringa JJ
Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.
Schuringa JJ; Chung KY; Morrone G; Moore MA
J Exp Med; 2004 Sep; 200(5):623-35. PubMed ID: 15353555
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
De Bruyn C; Delforge A; Martiat P; Bron D
Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
[TBL] [Abstract][Full Text] [Related]
16. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells.
Mayani H; Dragowska W; Lansdorp PM
Blood; 1993 Jun; 81(12):3252-8. PubMed ID: 7685200
[TBL] [Abstract][Full Text] [Related]
18. STAT5 signaling in normal and pathologic hematopoiesis.
Bunting KD
Front Biosci; 2007 May; 12():2807-20. PubMed ID: 17485261
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
[TBL] [Abstract][Full Text] [Related]
20. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
